Renaissance Technologies - IMMUNOPRECISE ANTIBODIES LTD ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q3 2023$27
-100.0%
14,600
-16.1%
0.00%
Q2 2021$105,00017,4000.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q4 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 970,147$5,0540.28%
Gradient Capital Advisors, LLC 26,808$139,6700.06%
KRAEMATON INVESTMENT ADVISORS, INC 1,600$8,3360.01%
WEST PACES ADVISORS INC. 1,665$8,6750.00%
Tower Research Capital LLC (TRC) 2,432$130.00%
BANK OF MONTREAL /CAN/ 240,980$1,247,6600.00%
CIBC WORLD MARKET INC. 47,427$2510.00%
DIMENSIONAL FUND ADVISORS LP 27,661$1460.00%
BANK OF AMERICA CORP /DE/ 2,000$10,4200.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders